For the first time, scientists put both medications head-to-head in a rigorous clinical trial and in May 2025, the results were published in the New England Journal of Medicine , the most respected medical journal in the world.[1] Here in Shreveport and across northwest Louisiana, where nearly 40% of adults are living with obesity, this study matters
Partial biotinidase deficiency is characterized by enzyme activity that is 10%30% of normal
Other emerging obesity and diabetes treatments are also being studied
The ketogenic diet and cardiovascular diseases
Most tanning pills contain canthaxanthin, which is more commonly used as a reddish-orange food coloring
One previous study, published in JAMA, looked at data from nearly 1.5 million people